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 BACKGROUND:  Surface major histocompatibility complex class I-related chain (MIC) A and B 
mol ecules are increased by IL-15 and have a role in the activation of natural killer group 2 
member D-positive natural killer and CD8 T cells. MICA and MICB also exist in soluble forms 
(sMICA and sMICB). Rhinoviruses (RVs) are the major cause of asthma exacerbations, and 
IL-15 levels are decreased in the airways of subjects with asthma. Th e role of MIC molecules in 
immune responses in the lung has not been studied. Here, we determine the relationship 
between MICA and MICB and RV infection in vitro in respiratory epithelial cells and in vivo 
in healthy subjects and subjects with asthma. 
 METHODS:  Surface MICA and MICB, as well as sMICA and sMICB, in respiratory epithelial cells 
were measured in vitro in response to RV infection and exposure to IL-15. Levels of sMICA and 
sMICB in serum, sputum, and BAL were measured and correlated with blood and bronchoalveo-
lar immune cells in healthy subjects and subjects with asthma before and during RV infection. 
 RESULTS:  RV increased MICA and MICB in vitro in epithelial cells. Exogenous IL-15 upregu-
lated sMICB levels in RV-infected epithelial cells. Levels of sMICB molecules in serum were 
increased in healthy subjects compared with subjects with stable asthma. Following RV infec-
tion, airway levels of sMIC are upregulated, and there are positive correlations between spu-
tum MICB levels and the percentage of bronchoalveolar natural killer cells in healthy subjects 
but not subjects with asthma. 
 CONCLUSIONS:  RV infection induces MIC molecules in respiratory epithelial cells in vitro and 
in vivo. Induction of MICB molecules is impaired in subjects with asthma, suggesting these 
molecules may have a role in the antiviral immune response to RV infections.
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 Respiratory virus infections, particularly by rhinovi-
ruses (RVs), are a major cause of morbidity and mor-
tality and the most common triggers of asthma 
exacerbations. Th e mechanisms of these virus-induced 
asthmatic exacerbations remain poorly understood. 
Respiratory viruses primarily enter and replicate in 
epithelial cells in the respiratory tract and epithelial 
cells play a key role in initiating and modulating immune 
responses to infection. Epithelial cells express surface 
molecules such as the major histocompatibility 
complex (MHC) class I molecules that could activate 
cytotoxic T cells. 1,2 New molecules related to MHC 
class I molecules, the MHC class I-related chain (MIC) 
A and B molecules, have been reported to be upregu-
lated on stressed and/or rapidly proliferating cells, 
which includes pathogen-infected cells. 3 Surface MIC 
molecules bind the nonspecifi c activatory receptor nat-
ural killer (NK) group 2 member D (NKG2D), leading 
to activation of NK and CD8 T cells and, therefore, 
may be important in promoting immune responses to 
virus infections. 4-6 
 MICA and MICB are also released in biologic fl uids as 
soluble MIC molecules (sMICA and sMICB). 7,8 How-
ever, even in data reports, levels of MICA and MICB 
were measured together by using an antibody recog-
nizing both MICA/MICB (anti-MICA/B monoclonal 
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antibodies clones 6D4). 9,10 Individual antibodies to iden-
tify sMICA and sMICB molecules individually recently 
became available. 
 Innate cytokines induced by viruses, type 1 interferons 
and IL-15, modulate each other and have an important 
role in antiviral immune responses. In addition, they 
increase surface MICA/MICB in dendritic cells, mac-
rophages, and intestinal epithelial cells. 11-14 Subjects 
with asthma have increased susceptibility to RV infec-
tions, and a defi cient type 1 antiviral immune response 
has been suggested as one of the mechanisms involved 
in RV-induced asthma exacerbations. 15-19 Epithelial 
and BAL cells exposed in vitro to RV demonstrated 
impaired production of innate interferons in atopic 
subjects with asthma, and these defi ciencies were 
related to severity of RV-induced asthma exacerbations 
in vivo. 17,18 In addition, both BAL IL-15 levels and 
induction of IL-15 in vitro by RV in alveolar macro-
phages are defi cient in subjects with mild asthma, and 
these defi ciencies are related to virus load and disease 
severity in vivo during a subsequent experimental RV 
infection. 19 
 We previously reported that infection of respiratory 
epithelial cells in vitro with respiratory syncytial virus 
increased IL-15 and surface MICA and sMICA levels. 2 
However, the role of RV and IL-15 in the modulation 
of surface MICA and MICB and sMICA and sMICB in 
respiratory epithelial cells and the role of sMICA and 
sMICB in RV infection in healthy subjects and in 
virus-induced asthma exacerbations are not known. 
We investigated in vitro the cell surface and soluble 
levels of MICA and MICB in RV-infected epithelial 
cells and investigated the role of exogenous IL-15 on 
MICA and MICB levels in RV-infected epithelial cells. 
Finally, we correlated sMICA and sMICB levels in bio-
logic fl uids (serum, sputum, and BAL) to the immune 
responses and clinical illness severity in vivo in healthy 
subjects and subjects with asthma exposed to an exper-
imental RV infection. 
 We report here that in vitro there is increased produc-
tion of sMICA and sMICB molecules in RV-infected 
epithelial cells and that exogenous IL-15 increased sur-
face MICB and sMICB levels. In vivo levels of serum 
sMICB are decreased in subjects with asthma as com-
pared with healthy subjects, and sMICB molecules in 
the airways correlated to the percentage of NK cells in 
BAL and sMICB levels in serum correlated to upper and 
lower respiratory symptoms during RV infection in 
healthy subjects. 
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 Materials and Methods 
 RV16 (major group RVs) and RV1B (minor group RV) stocks were pre-
pared and their identities confi rmed by neutralization using serotype-
specifi c antibodies (American Type Culture Collection). To assess the 
specifi city of live RV-mediated responses, we used ultraviolet (UV)-
inactivated and fi ltered RV (produced by passing RV stocks through 
a 30-kDa membrane; EMD Millipore Corp). 1 Bronchial epithelial cells 
(BEAS-2B) (European Collection of Cell Cultures) were cultured and 
infected with RV as previously described. 1,20 Semiconfl uent cell mono-
layers were exposed to RV at diff erent multiplicity of infections (MOIs) 
(infectious units per cell) or inactivated RV for 1 h with gentle shak-
ing, the virus was washed, and fresh medium   IL-15 (5 ng/mL) (R&D 
Systems, Inc) was added. Time zero (0 h) was considered the moment 
when virus was removed. Cells and supernatants were harvested at dif-
ferent time points 24, 48, 72, and 96 h. 
 Flow cytometry was used to determine surface levels of MICA and 
MICB. Epithelial cells were harvested at different time points and 
processed as previously described. 21 Surface MICA and MICB were 
detected on cells by direct staining using mouse anti-human anti-
bodies: MICA (phycoerythrin) and MICB (allophycocyanin) (all 
from R&D Systems, Inc). 2 At least 10,000 events were acquired using 
a BD LSR flow cytometer and CellQuest software (BD Biosciences). 
Results were expressed as mean fl uorescent intensity (MFI) aft er sub-
tracting the MFI of the control cells stained with the appropriate isotype 
control antibodies. Stimulation experiments were expressed as fold 
increase of MFI of experimental condition over medium-treated cells 
of at least three separate experiments (three to six experiments). 
 Th e clinical details, including allergy testing and lung function, sam-
pling and analysis of the experimental infection model, have already 
been described in detail. 16 Th e study recruited 15 nonatopic healthy 
control subjects and 10 atopic, inhaled steroid-naive subjects with 
asthma; all were nonsmokers and negative for RV16 serum-neutralizing 
antibodies. Th e asthmatic group was required to have a provocative 
concentration causing a 20% drop in FEV 1  , 8 mg/mL on histamine 
challenge. In addition, a provocative concentration causing a 10% drop 
in FEV 1 was determined in both patients with asthma and normal 
subjects. Th eir demographic and clinical features are described in de-
tail elsewhere. 16 Ethics approval (no. 99/BA/345) was obtained from 
St. Mary’s Local Research Ethics Committee (London, England). All 
study participants gave written informed consent. Serum, sputum, and 
BAL were collected at baseline approximately 2 weeks prior to RV infection 
as previously described. 16 Two weeks later, the same subjects were 
experimentally infected with RV16, and MICA and MICB levels were 
measured in serum (at day 3, 4, 7, and 6 weeks aft er infection), sputum 
(at day 3, 7, and 6 weeks aft er infection), and BAL fl uid (at day 4 and 
6 weeks aft er infection). Virus load was measured using quantitative 
polymerase chain reaction as described. 16 Symptom severity during 
the 2 weeks postinfection was derived using daily diary cards to score 
upper respiratory (cold) and lower respiratory (chest) symptoms as 
described. 16 Peripheral blood cell counts were measured in the Clinical 
Biochemistry and Hematology Laboratories of St. Mary’s Hospital, 
Imperial College Healthcare NHS Trust. 
 BAL was collected in a single plastic chamber and transferred imme-
diately to polypropylene tubes on ice for transport to the laboratory. Th e 
BAL cell pellet was used for cytospin preparations for diff erential cell 
  
 Figure 1 – RV infection increases in vitro levels of soluble MICA and MICB in bronchial respiratory epithelial cells. BEAS-2B respiratory epithelial cells 
were infected with RV1B and RV16 at diff erent concentrations, or cultured with medium alone or fi ltered virus, and soluble MIC levels measured in 
culture supernatants by enzyme-linked immunosorbent assay at diff erent time points. A-B, RV1B and RV16 increased soluble MICA (A) and soluble 
MICB (B) in BEAS-2B culture supernatants. C-D, RV1B increased levels of soluble MICA and MICB in a dose-responsive manner. Data are 
means   SEMs of three to eight experiments. An asterisk (*) over columns represent comparisons with medium alone. * P  , .05; ** P  , .01; *** P  , .001. 
MIC  5 major histocompatibility complex class I-related chain; MOI  5 multiplicity of infection; RV  5 rhinovirus. 
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 Figure 2 – RV infection increases IL-15 protein levels, and IL-15 increases MIC levels in bronchial respiratory epithelial cells. A, BEAS-2B cells were 
treated with RV1B MOI 1 or medium alone up to 72 h and IL-15 levels determined at diff erent time points. B, BEAS-2B cells were infected with RV1B at 
diff erent concentrations, fi ltered virus or medium alone, supernatants were harvested at 48 h, and levels of IL-15 measured. C-D, BEAS-2B cells were 
treated with RV1B MOI 1, fi ltered virus, IL-15, and RV1B  1 IL-15, supernatants harvested at 48 h, and levels of MICA and MICB determined. Data 
are means   SEMs of three to six experiments. An asterisk (*) over columns represent comparisons with medium alone. * P  , .05; ** P  , .01; *** P  , .001. 
See  Figure 1 legend for expansion of abbreviations. 
counting as described. 16 Surface staining of fresh blood and BAL cells 
with conjugated antibodies and analysis by three-color and four-color 
fl ow cytometry was performed as previously described 16 to assess the 
percentage and total cell numbers of lymphocytes, T cells (CD3  1  ), 
CD4 T cells (CD3  1  CD4  1  CD8  2  ), CD8 T cells (CD3  1  CD8  1  CD4  2  ), NK 
T cells (CD3  1  CD16/56  1  ), and NK cells (CD3  2  CD16/56  1  ). Analysis 
was performed on at least 10,000 lymphocyte events using CellQuest 
(BD Biosciences) and Winlist (Verity Soft ware House) soft ware. 
 MICA and MICB levels were measured in cell supernatants and biologic 
fl uids using paired antibodies and standards (DuoSet; R&D Systems, 
Inc). Assay sensitivities were 15.62 pg/mL (MICA) and 39.06 pg/mL 
(MICB). Levels of IL-15 were measured in cell supernatants by 
enzyme-linked immunosorbent assay using commercially available 
paired antibodies (R&D Systems, Inc) (sensitivity 0.39 pg/mL). 2,19 
 Statistical Analysis 
 The results were analyzed using GraphPad Prism (GraphPad 
Software). Results of in vitro experiments were expressed as 
mean   SEM. Analysis of variance, followed where appropriate by 
paired Student  t test, was used for the comparisons between differ-
ent experimental conditions. Correlations were determined by using 
Spearman rank correlation.  P values  , .05 were considered statisti-
cally significant. 
 Results 
 RV Infection Increases MIC 
 Surface MICA levels on epithelial cells were increased 
by RV1B at 24 h, and this was replication-dependent 
(UV-inactivated RV1B did not increase surface MICA) 
and dose-dependent (MFI was 7.9   1.6 for medium-
treated cells, 11.1   0.9 for UV-RV1B-treated cells, 
40.7   13.3 for RV1B MOI of 1, and 46.3   13.3 for RV1B 
MOI of 3;  P  , .05 medium vs RV1B MOI of 3, and  P  , .05 
RV1B MOI of 3 vs MOI of 1, data not shown). Surface 
MICB levels on epithelial cells were not found to be 
upregulated by RV infection at 24 h (MFI was 88.9   25.1 
for medium-treated cells, 16   10.1 for RV1B MOI of 1, 
and 5.1   4.1 for RV1B MOI of 3, data not shown). 
 Levels of sMICA and sMICB in supernatants from 
respiratory epithelial cells infected with RV1B were 
significantly increased (at 72 h for MICA and 
starting earlier, at 48 h for MICB) ( Figs 1A, 1B ). 
RV1B increased sMICA and sMICB levels in a time-
dependent, dose-dependent, and replication-dependent 
manner ( Fig 1 ). Similar data were found using 
RV16 with significant induction of sMICA observed 
at 48 and 72 h and sMICB at 24, 48, and 72 h 
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( Figs 1A, 1B ), indicating that the sMIC induction is 
RV-serotype independent. sMICB levels increased 
earlier and were at least 10 times higher as compared 
with sMICA levels in RV-infected epithelial cell 
supernatants. 
 RV Infection Increases IL-15 Production 
 RV1B and RV16 infection increased soluble IL-15 levels 
in supernatants from respiratory epithelial cells in a dose-
dependent, replication-dependent, and time-dependent 
manner ( Figs 2A, 2B , and data not shown). Addition of 
exogenous IL-15 to uninfected epithelial cells increased 
sMICA and sMICB level culture supernatants ( P  5 .053, 
respectively,  P  5 .079) ( Figs 2C, 2D ). 
 Addition of exogenous IL-15 to RV1B-infected 
epithelial cells had no eff ect on surface ( P  5 nonsignifi -
cant, data not shown) and sMICA at 24 h postinfection 
( Fig 2C ) ( P  5 nonsignifi cant). However, IL-15 increased 
surface MICB levels at 24 h postinfection ( P  , .01 vs 
RV1B-infected cells, data not shown) and sMICB mole-
cules at 48 h postinfection (RV1B vs RV1B  1 IL-15, 
 P  5 .01) ( Fig 2D ). 
 sMICA and sMICB Levels During RV Infection 
 At baseline, prior to infection, there were no signifi cant 
diff erences between the groups in levels of sMICA and 
sMICB in sputum and BAL and levels of sMICA in serum 
( Figs 3A-E ). However, serum sMICB levels at baseline 
  
 Figure 3 – A-F, Soluble MICA and soluble MICB levels in biologic fl uids during an experimental RV16 infection in normal subjects and patients with 
asthma. Levels of soluble MICA and soluble MICB in normal subjects and patients with asthma at baseline, during the acute experimental RV infection, 
and at convalescence (6 weeks postinfection) in (A, B) induced sputum, (C, D) BAL fl uid, and (E, F) serum. Data are mean and SEM. * P  , .05. See 
 Figure 1 legend for expansion of abbreviations. 
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were signifi cantly lower in atopic subjects with asthma 
as compared with normal subjects ( Fig 3F ) ( P  5 .03). 
 Th ere were no signifi cant changes in sMICA and 
sMICB levels in sputum or BAL in the subjects with 
asthma following RV infection. However, in healthy 
subjects, levels of sMICA and sMICB increased dur ing 
RV infection in sputum between days 3 and 7 ( Figs 3A, 
3B ). Th ere was a trend toward signifi cantly increased 
levels of sMICA and sMICB in BAL at day 4 postinfec-
tion as compared with baseline ( Figs 3C, 3D) ( P  5 .07 
and  P  5 .09, respectively) in the normal subjects. 
 sMICA levels positively correlated with sMICB levels in 
BAL in both healthy subjects and subjects with asthma 
prior to RV16 infection and at day 4 postinfection and 
in serum prior to RV16 infection ( Table 1 ). Prior to RV 
infection there were also positive correlations between 
sMICA levels in serum and in BAL (all subjects: 
 r  5 0.47,  P  5 .036; normal subjects:  r  5 0.578,  P  5 .03) 
and between sMICB levels in serum and in BAL (all 
subjects:  r  5 0.512,  P  5 .029) ( Fig 4A ). 
 During RV infection, serum sMICB negatively corre-
lated with blood neutrophil ( r  5  2 0.561,  P  5 .036) and 
to BAL total lymphocyte numbers ( r  5  2 0.593, 
 P  5 .032) in healthy subjects ( Fig 4B ). At the peak of RV 
infection in healthy subjects, sMICB levels in sputum 
correlated with frequency of NK cells in BAL and 
sMICA levels in BAL negatively correlated to the 
number of NK cells in blood ( Fig 4B ). Concerning 
clinical symptoms during virus infection, serum 
sMICB on days 3 to 4 correlated to upper ( r  5 0.564, 
 P  5 .044) and to lower respiratory symptoms 
( r  5 0.519,  P  5 .056) ( Fig 4B ) in healthy subjects. 
 Discussion 
 Th e present study is, to our knowledge, the fi rst investi-
gation of the potential role of MICA and MICB mole-
cules in the pathogenesis of RV infection in healthy 
subjects and subjects with asthma. We report that RV 
infection of respiratory epithelial cells in vitro 
increased the levels of soluble MIC molecules MICA 
and MICB, and that exogenous IL-15 potentiated RV 
induction of sMICB molecules. Serum levels of sMICB 
are reduced in stable patients with asthma compared 
with healthy subjects and, following RV infection, spu-
tum and BAL soluble MIC molecule levels are 
increased in healthy subjects, but not in patients with 
asthma. Interestingly, during RV infection sMICB 
levels in the airways correlated with increased number 
of BAL NK cells in healthy subjects. sMICB levels in 
serum correlated with clinical markers of dis ease 
severity in the healthy subjects, suggesting that these 
molecules may have a role in increased inflammation 
as a consequence of activation of immune response 
to RV. 
 Th e balance between inhibitory and activatory mole-
cules/ligands on antigen-presenting cells determines 
whether NK and CD8 T cells are activated or inhibited 
to kill virus-infected cells. 22 We previously reported 
that RV infection increases levels of MHC class I mole-
cules in respiratory epithelial cells, 1 suggesting that NK 
cells will be inhibited, and antiviral CD8 T cells acti-
vated, by virus antigen presentation. However, the acti-
vation of antiviral immune responses can also be 
nonspecifi c, via surface MICA/MICB molecules which 
bind NKG2D on NK cells and CD8 T cells. 4,23 High 
levels of NKG2D stimulation via MICA/MICB can 
override the inhibitory signaling provided by MHC 
class I recognition to NK cells. 23-25 In the current study, 
we demonstrated that in vitro RV infection of respira-
tory epithelial cells upregulated surface expression of 
MICA and soluble levels of both MICA and MICB. Th e 
mechanisms of production of soluble MIC molecules 
have yet to be determined but it is likely that soluble 
molecules result from the detachment of cell-surface 
 TABLE 1 ]  Relationship of sMICA With sMICB Levels 
in Biologic Fluid During an RV16 Virus 
Infection 
 Fluid All Subjects Normal Subjects
Subjects With 
Asthma 
 BAL  
 Baseline  1 0.80 a  1 0.71 a  1 0.86 a 
 Day 4 pi  1 0.78 a  1 0.60 a  1 0.94 a 
 6 wk pi  1 0.71 a  1 0.77 a … 
 Serum  
 Baseline  1 0.75 a  1 0.66 a  1 0.84 b 
 Day 3 pi  1 0.84 a  1 0.79 a … 
 Day 4 pi  1 0.69 a  1 0.60 b  1 0.70 c 
 Day 7 pi  1 0.54 a  1 0.79 a … 
 6 wk pi  1 0.65 a  1 0.72 a … 
 Sputum  
 Baseline … … … 
 Day 3 pi 0.39 c … … 
 Day 7 pi 0.36 c … … 
 6 wk … … … 
 Data show the Spearman rank correlation coeﬃ  cient ( r ). pi  5 postin-
fection; RV  5 rhinovirus; sMIC  5 soluble major histocompatibility 
complex class I-related chain. 
 a P  , .01. 
 b P  , .05. 
 c P  , .1. 
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MIC molecules. Increased levels of sMICA were found 
at later time points compared with cell-surface MICA 
and sMICB molecules increased earlier in cell superna-
tants compared with MICA. A possible explanation for 
the discrepancy seen between surface MICB and 
sMICB levels is that surface MICB is induced at an ear-
lier time point than 24 h, which was the fi rst time point 
at which we measured its expression. It has been 
reported that surface MICA and MICB molecules are 
regulated diff erently with MICB having a much shorter 
half-life at the plasma membrane. 26 Th erefore, these 
fi ndings support our hypothesis that soluble MIC mol-
ecules are likely to refl ect cell-surface levels. 
 We have previously reported that RV infection 
increases IL-15 production in alveolar macrophages, 19 
and, therefore, we added exogenous IL-15 to determine 
its eff ect on virus-induced MICA and MICB in respira-
tory epithelial cells. In the presence of IL-15, RV infec-
tion signifi cantly increased surface levels of MICB at 
24 h and sMICB levels at 48 h. Th erefore, the presence 
of a microenvironment with high IL-15 levels will favor 
increased expression of MICB. 
  
 Figure 4 – Relationships between soluble MIC levels to infl ammatory cell type and to markers of clinical illness during an experimental RV16 infection. 
A, Relationships between serum and BAL MIC levels. B, Relationships between airway MIC levels and infl ammatory cells and serum MIC levels and 
disease severity during a follow-up RV infection are shown. Data are mean and SEM. NK  5 natural killer. See  Figure 1 legend for expansion of other 
abbreviations. 
 journal.publications.chestnet.org 39
 To investigate the role of MIC molecules in RV infec-
tion in vivo, we measured levels of sMICA and sMICB 
in sputum and BAL in healthy subjects and subjects 
with asthma before and during an experimental RV 
infection. As bronchial tissue samples to directly mea sure 
surface MIC molecules were not available, we measured 
soluble MIC molecules in airway secretions as a surro-
gate marker of surface MIC expression. Following RV 
infection, soluble MIC molecule levels were increased in 
sputum and BAL in healthy subjects, but not subjects 
with asthma. Th ese data suggest that in subjects with 
asthma there is a failure of upregulation of MIC mole-
cules following virus infection. We have previously dem-
onstrated that asthma is associated with IL-15 defi ciency 
and impaired virus induction of IL-15. 19 Th erefore, 
impaired induction of IL-15 following virus infection may 
be a mechanism of reduced MIC expression in asthma. 
 Th ere were positive correlations between sputum MICB 
levels and the percentage of BAL NK cells, and inverse 
correlations between BAL MICA levels and blood NK 
cells in healthy subjects. We have previously demon-
strated inverse relationships between blood and BAL 
lymphocytes in experimental RV infection, presumably 
refl ecting recruitment of lymphocytes to the lungs from 
the blood in response to infection. Th erefore, reduced 
levels of MIC may be associated with reduced recruitment 
of NK cells and impaired antiviral immunity in asthma. 
 Th ere are several limitations to our study, including the 
small sample size and the inclusion of subjects with mild 
asthma only. Th ese factors may have contributed to fail-
ure to detect more signifi cant diff erences between the 
groups. However, experimental RV infection studies 
are, by ethical reasons, restricted to small numbers of 
subjects with mild asthma, but provide useful hypothe-
sis-generating human translational data that can be fur-
ther investigated in controlled clinical trials performed 
on larger groups of patients and with more severe 
asthma. Furthermore, we have assumed based on our in 
vitro data that soluble MIC levels refl ect cell-surface 
levels. However, further studies are required to deter-
mine whether soluble levels of MIC molecules refl ect 
cell-surface expression in vivo and the relationships 
between MIC molecules and IL-15 and whether soluble 
MIC molecules play an active role in upregulating im-
mune responses or simply refl ect cleavage and removal 
of surface MIC molecules and, therefore, are a surrogate 
marker for cellular levels. 
 In conclusion, our results suggest that MIC levels in the 
airways are increased in response to virus infection in 
healthy subjects, but not subjects with asthma, and air-
way MICB levels correlated with NK cells at the peak of 
the RV infection. Impaired expression of MIC may be a 
mechanism of increased severity of clinical illness 
following virus infection in patients with asthma. 
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